More on NVCR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.68 |
|
|||
| Open | $14.68 | ||||
| 52 Wk High | $28.95 | ||||
| 52 Wk Low | $5.95 | ||||
| Day High | $14.68 | ||||
| Day Low | $14.68 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 89 | ||||
- Form 8-K NovoCure Ltd For: Oct 01
- Novocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer
- Novocure to Report Third Quarter 2026 Financial Results
- NovoCure reports data breach affecting over 1,400 patient records
- NovoCure Ltd. (NVCR) PT Raised to $20 at Wedbush
- NovoCure Ltd. (NVCR) PT Lowered to $32 at H.C. Wainwright
- NovoCure Ltd. (NVCR) PT Raised to $20 at Wells Fargo
- Form 144 NovoCure Ltd Filed by: Leupin Nicolas
- Novocure (NVCR) Tops Q2 EPS by 20c; offers guidance
- Form 8-K NovoCure Ltd For: Jul 23
Entities mentioned with NVCR
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
